Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,607.95
(
0.11%
)
US TECH 100
29,782.17
(
0.24%
)
Dow Jones
51,172.23
(
0.18%
)
Brent Oil
94.81
(
-1.21%
)
Bitcoin
67,494.40
(
-5.43%
)
News Focus
News Focus
Post# of 519083
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

kevli33

Send PM Follow Ignore
Followers 9
Posts 921
Boards Moderated 0
Alias Born 05/12/2005

kevli33

Re: tradeherpete post# 187827

Monday, 04/01/2019 1:10:17 PM

Monday, April 01, 2019 1:10:17 PM

Post# of 519083

The P-2a AD study which is now an extension study of the initial 32 patients and lasting now 208 weeks, which was initially a PK study lasting for 5 weeks and then has been extended thereafter in multiple occasions now reaching full 5 year, over 5 year period of observing safety and also exploratory efficacy.



Wow...seeing that number again and again....come on Aussies...citizens...think of your fellow citizens.

Anavex Now!


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News